Vidarbha News

In vivo CRO Market: Worldwide Changing Supply And Demand Scenarios By 2026 | Grand View Research, Inc.

 Breaking News
  • No posts were found

In vivo CRO Market: Worldwide Changing Supply And Demand Scenarios By 2026 | Grand View Research, Inc.

August 03
03:41 2021
In vivo CRO Market: Worldwide Changing Supply And Demand Scenarios By 2026 | Grand View Research, Inc.

“Grand View Research, Inc. – Market Research And Consulting.”
According to a new report published by Grand View Research, increasing frequency of outsourcing R&D activities by the major pharmaceutical companies to focus on their core competencies is the major growth driver.

The global in vivo cro market is anticipated to reach USD 5.81 billion by 2026, according to a new report by Grand View Research, Inc. It is expected to expand at a CAGR of 8.5% during the forecast period. Increasing focus on core competencies by the pharmaceutical players coupled with economic efficiency offered for outsourcing is expected to boost the demand.

In Addition, the CROs are equipped with a competent workforce capable of performing a diverse number of tasks along with being well-versed through regulatory requirements. Also, the pressure from the increasing competition owing to rapid growth of generics, patent expirations, and introduction of biosimilar equivalents are encouraging pharmaceutical companies to take the aid of such organizations.

Increasing mergers and collaborations have propelled the value of pharmaceutical outsourcing with major industry contributors expanding into developing regions. The year 2015 experienced high valued transactions as a result of LabCorp acquiring Covance for USD 5.5 billion and the Chinese Private Equity Group acquiring WuXifor USD 3.3 billion.

In vivo CRO Market Report Highlights

 Rodent based In vivo CRO led the market in 2018 and is anticipated to remain dominant throughout the forecast period. Mice is the most used animal for preclinical evaluation and accounted for almost 76% of the market share in 2018.

 Based on indication, oncology held the largest market share in 2018, attributed to the increasing number of cancer cases and focus of pharmaceutical players on introducing novel drug treatments with fewer side-effects

 North America led the global In vivo CRO market in 2018 owing to the presence of technologically advanced CROs

 Asia Pacific is anticipated to register the fastest CAGR over the forecast period. Constantly improving healthcare infrastructure, huge patient base, presence of untapped opportunities, and economic development, are some factors responsible for the rapid growth

 Some of the key market players include Pharmaceutical Product Development, LLC (PPD); IQVIA; American Preclinical Services, LLC.; Charles River Laboratories; Parexel International Corporation; ICON Plc; Covance Inc.; Theorem Clinical research; inVentiv Health; WuXi AppTec, Inc.; American Preclinical Services, LLC.; and Evotec (US), Inc. Partnership and mergers and acquisitions are the key strategic undertakings by these players

Browse full report with Table of Content @

In vivo CRO Market Segmentation

Grand View Research has segmented the In vivo CRO market based on product type, GLP type, indication, and region:

In vivo CRO Product Type Outlook (Revenue, USD Million, 2015 – 2026)

     Rodent Based
        • Rats
        • Mice
        • Others
     Non-Rodent Based
        • Hamsters
        • Guinea Pigs
        • Gerbils
        • Others

In vivo CRO GLP Type Outlook (Revenue, USD Million, 2015 – 2026)

     Autoimmune/Inflammatory Conditions
        • Rheumatoid Arthritis
        • Multiple Sclerosis
        • Osteoarthritis
        • Irritable Bowel Syndrome
        • Others

     Pain Management
        • Chronic Pain
        • Acute Pain

In vivo CRO Indication Outlook (Revenue, USD Million, 2015 – 2026)

     Non GLP
        • In House
        • Outsourcing
     GLP Toxicology
        • In House
        • Outsourcing

        • Blood Cancer
        • Solid Tumor
            • Syngeneic Model
            • Patient Derived Xenograft
            • Xenograft
        • Others

     CNS conditions
        • Epilepsy
        • Parkinson’s Disease
        • Huntington’s Disease
        • Stroke
        • Traumatic Brain Injury
        • ALS
        • Muscle Regeneration
        • Others

        • Obesity
        • Others

In vivo CRO Regional Outlook (Revenue, USD Million, 2015 – 2026)

     North America
        • U.S.
        • Canada
        • Germany
        • U.K.
        • Spain
        • Italy
        • France

     Asia Pacific
        • China
        • India
        • Japan
        • Australia
        • South Korea
    • Latin America
        • Brazil
        • Mexico
        • Argentina
        • Colombia

     Middle East & Africa
        • Saudi Arabia
        • UAE
        • South Africa

For Requesting a Sample Copy of This Report, Please Visit @

Browse More Related Report:

Oncology Based In-vivo CRO Market Analysis By Indication (Blood cancer, Solid tumor), By Model (Syngeneic model, Patient Derived Xenograft (PDX), Xenograft), By Region, And Segment Forecasts, 2018 – 2025

Preclinical CRO Market Size, Share & Trends Analysis Report By Service (Toxicology Testing, Bioanalysis & DMPK Studies), By End-use (Biopharmaceutical Companies, Government & Academic Institutes), And Segment Forecasts, 2021 – 2028

About Grand View Research

Grand View Research is a U.S. & India-based market research and consultancy firm. It is headquartered in San Francisco. We provide business insights, syndicated research reports, and customized research reports to large as well as small and medium-scale enterprises. Our database features thousands of statistics and in-depth analyses on more than 45 industries. Grand View Research’s extensive database is used by Fortune 500 companies to understand the regional as well as the global business environment.

Media Contact
Company Name: Grand View Research, Inc.
Contact Person: Sherry James, Corporate Sales Specialist – U.S.A.
Email: Send Email
Phone: 1888202951
Address:Grand View Research, Inc. 201 Spear Street 1100 San Francisco, CA 94105, United States
City: San Francisco
State: California
Country: United States